AXA S.A. announces the launch of a Secondary Offering of AXA Equitable Holdings, Inc.’s Common Stock

AXA S.A. (“AXA”) announces today the launch of a secondary public offering of the shares of common stock of its U.S. subsidiary, AXA Equitable Holdings, Inc. (“EQH”), and the commencement of the roadshow for the public offering.

AXA, as selling stockholder, is offering 50,000,000 shares* of common stock of EQH, and has granted the underwriters a 30-day option to purchase up to an additional 7,500,000 shares of common stock.

In connection with the public offering, AXA has entered into a share repurchase agreement with EQH pursuant to which AXA will sell to EQH, subject to certain terms and conditions, between 20,000,000 and 30,000,000 shares of EQH’s common stock. The share repurchase is subject to a number of conditions, including the successful completion of the public offering.

The shares are being offered by a group of underwriters led by J.P. Morgan, Morgan Stanley, and Citigroup. Copies of the preliminary prospectus relating to the offering may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, New York 11717 or telephone: 866-803-9204; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; and Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or telephone: 800-831-9146.

A registration statement relating to the proposed public offering has been filed by EQH with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

*Out of 558,526,870 total common outstanding shares, as of September 30th, 2018.